145 related articles for article (PubMed ID: 4122513)
1. Rejection of tumor cells in vitro.
Berczi I; Strausbauch P; Sehon AH
Science; 1973 Jun; 180(4092):1289-91. PubMed ID: 4122513
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of subpopulations of immune lymphocytes against murine sarcoma cells.
Lamon EW; Wigzell H
Transplantation; 1974 Oct; 18(4):368-71. PubMed ID: 4547517
[No Abstract] [Full Text] [Related]
3. Solubilized tumour-associated antigens of methyl-cholanthrene-induced mouse sarcomas. Comparative studies by in vitro sensitization of lymph-node cells, macrophage electrophoretic mobility assay and transplantation tests.
Bubeník J; Indrová M; Nemecková S; Malkovský M; Von Broen B; Pálek V; Anderlíková J
Int J Cancer; 1978 Mar; 21(3):348-55. PubMed ID: 75857
[No Abstract] [Full Text] [Related]
4. Selective reaction of effector lymphocytes of transplantation immunity to private specificities of the H-2K and H-2D loci.
Brondz BD; Egorov IK
Bull Exp Biol Med; 1974 Dec; 77(6):659-62. PubMed ID: 4140743
[No Abstract] [Full Text] [Related]
5. Efferent enhancement of a methylcholanthrene-induced sarcoma transplantable in strain 13 guinea pigs.
Berczi I; Tsay HM; Sehon AH
Eur J Immunol; 1976 Jun; 6(6):453-5. PubMed ID: 991912
[TBL] [Abstract][Full Text] [Related]
6. Cell-mediated cytotoxicity of adherent and non-adherent mouse lymph node cells sensitized in vitro against tumour-associated antigens of syngenetic methylcholanthrene-induced sarcomas.
Indrová M; Bubeník J
Folia Biol (Praha); 1979; 25(2):137-41. PubMed ID: 456694
[TBL] [Abstract][Full Text] [Related]
7. Phenotypes associated with tumor rejection mediated by cyclophosphamide and syngeneic tumor-sensitized T lymphocytes: potential mechanisms of action.
Evans R
Int J Cancer; 1984 Mar; 33(3):381-8. PubMed ID: 6607893
[TBL] [Abstract][Full Text] [Related]
8. Tumor-specific and allospecific immunogenicity of soluble extracts from chemically induced murine sarcomas.
Pellis NR; Tom BH; Kahan BD
J Immunol; 1974 Aug; 113(2):708-11. PubMed ID: 4136043
[No Abstract] [Full Text] [Related]
9. Proceedings: Immunologic similarities between fetal cell antigens and tumor cell antigens in guinea pigs.
Grant JP; Ladisch S; Wells SA
Cancer; 1974 Feb; 33(2):376-83. PubMed ID: 4812757
[No Abstract] [Full Text] [Related]
10. The effect of curative cryosurgery on the tumor-specific immune response of C57 mice.
Faraci RP; Bagley DH; Marrone JA; Beazley RM
Cryobiology; 1975 Apr; 12(2):175-9. PubMed ID: 1126183
[No Abstract] [Full Text] [Related]
11. Common transplantation antigens on methylcholanthrene-induced murine sarcomas detected by three assays of tumor rejection.
Leffell MS; Coggin JH
Cancer Res; 1977 Nov; 37(11):4112-9. PubMed ID: 908044
[No Abstract] [Full Text] [Related]
12. Use of Vaccinia virus as an adjuvant in inducing specific anti-tumour immunity to transplantable mouse fibrosarcoma. II. Rejection of tumour graft 'in vivo' humoral and lymphocytotoxicity 'in vitro'.
Bendre AR; Gangal SG
Indian J Cancer; 1978 Dec; 15(4):9-16. PubMed ID: 757692
[No Abstract] [Full Text] [Related]
13. Antigenicity of carcinogen and viral induced sarcomas in inbred and random bred guinea pigs.
Forni G; Rhim JS; Pickeral S; Shevach EM; Green I
J Immunol; 1975 Jul; 115(1):204-10. PubMed ID: 50348
[TBL] [Abstract][Full Text] [Related]
14. Host immunity to a growing transplanted methylcholanthrene-induced guinea pig sarcoma.
Cohen AM; Millar RC; Ketcham AS
Cancer Res; 1972 Nov; 32(11):2421-6. PubMed ID: 5082590
[No Abstract] [Full Text] [Related]
15. Cytotoxicity in vitro by products of specifically stimulated spleen cells: susceptibility of tumor cells and normal cells.
Meltzer MS; Bartlett GL
J Natl Cancer Inst; 1972 Nov; 49(5):1439-43. PubMed ID: 4568090
[No Abstract] [Full Text] [Related]
16. Cell surface antigens of murine leukemias induced by radiation leukemia virus. Recognition of individually distinct cell surface antigens by cytotoxic T cells on leukemias expressing crossreactive transplantation antigens.
Morishita H; Shiku H; Horibe K; Obata Y; Stockert E; Oettgen HF; Old LJ; Yamada K
J Exp Med; 1986 Feb; 163(2):452-7. PubMed ID: 3003228
[TBL] [Abstract][Full Text] [Related]
17. [Persistance of cytotoxic activity against a syngeneic tumor after removal of the tumor].
Lafontaine N; Firket H
C R Acad Hebd Seances Acad Sci D; 1973 Oct; 277(13):1261-3. PubMed ID: 4205925
[No Abstract] [Full Text] [Related]
18. Are methylcholanthrene-induced sarcoma-associated, rejection-inducing (TSTA) antigens, modified forms of H-2 or linked determinants?
Klein G; Klein E
Int J Cancer; 1975 Jun; 15(6):879-87. PubMed ID: 50291
[TBL] [Abstract][Full Text] [Related]
19. [Immunologic specificity of accelerated skin graft rejection with antigenic overlap in the H-2 system. Role of immune lymphocytes and antibodies].
Brondz BD
Biull Eksp Biol Med; 1972 Dec; 73(12):61-5. PubMed ID: 4118605
[No Abstract] [Full Text] [Related]
20. Immune response to an allogeneic progressively growing solid tumor.
Eggers AE
Cancer Res; 1976 Jun; 36(6):2085-9. PubMed ID: 773534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
